Filter Results:
(313)
Show Results For
- All HBS Web
(313)
- People (1)
- News (124)
- Research (147)
- Multimedia (13)
- Faculty Publications (95)
Show Results For
- All HBS Web
(313)
- People (1)
- News (124)
- Research (147)
- Multimedia (13)
- Faculty Publications (95)
- Forthcoming
- Article
Branch-and-Price for Prescriptive Contagion Analytics
By: Alexandre Jacquillat, Michael Lingzhi Li, Martin Ramé and Kai Wang
Contagion models are ubiquitous in epidemiology, social sciences, engineering, and management. This paper formulates a prescriptive contagion analytics model where a decision maker allocates shared resources across multiple segments of a population, each governed by... View Details
Jacquillat, Alexandre, Michael Lingzhi Li, Martin Ramé, and Kai Wang. "Branch-and-Price for Prescriptive Contagion Analytics." Operations Research (forthcoming). (Pre-published online March 13, 2024.)
- March 2022 (Revised July 2022)
- Case
Nexleaf Analytics: Saving the World Using the Internet of Things
By: Frank Nagle
In 2019, a decade after co-founding Nexleaf Analytics, CEO Nithya Ramanathan faced an important decision that would impact the ability of the small, but growing, not-for-profit organization to thrive for another decade. Their sensor technologies and big data analytics... View Details
Keywords: Corporate Strategy; Collaborative Innovation and Invention; Technological Innovation; Nonprofit Organizations; Competitive Strategy; Patents; Expansion; Information Technology; Health Industry; Information Industry; Medical Devices and Supplies Industry; Technology Industry
Nagle, Frank. "Nexleaf Analytics: Saving the World Using the Internet of Things." Harvard Business School Case 722-414, March 2022. (Revised July 2022.)
- Awards
Doing Good with Good O.R. Student Paper Competition
Runner-up for the 2021 Doing Good with Good O.R. Student Paper Award from the Institute for Operations Research and the Management Sciences (INFORMS) for “Data-driven COVID-19 Vaccine Development for Janssen" with Dimitris J. Bertsimas, Omar Skali Lami, Hamza Tazi... View Details
- 11 Jun 2020
- Working Paper Summaries
Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design
- 16 Nov 2020
- News
Weekend Edition
- 9 AM – 10 AM EDT, 19 Oct 2017
- Webinars: Trending@HBS
Innovative Finance for the Common Good
Whether it's a vaccine or green bond, drought insurance, pay-as-you-go financing for solar electricity in Kenya, or discounted metro cards in New York, innovative finance is as much about incentives and sound decision making as it is about money; when it works,... View Details
- 17 Mar 2021
- News
Beyond Pajamas: Sizing Up the Pandemic Shopper
- 20 Jan 2022
- News
Three Steps to Help Companies Rebuild Trust During the Pandemic
- 24 May 2022
- Blog Post
Get to Know 2022 Class Day Student Speaker Peter James Kiernan
service part of his DNA, he heeded the call to serve. From that lonely hotel room, Kiernan helped configure the state’s first mass vaccination sites for COVID-19. Kiernan was, as he laughingly puts it, in the wrong place at the wrong time... View Details
- December 2020 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (B)
By: Linda A. Hill and Emily Tedards
In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone three large-scale mergers and acquisitions. As Ku and his new leadership team set out to build a proactive, end-to-end, digital and physical clinical... View Details
Keywords: Digital Technology; Customer-centricity; Innovation; Customer Focus; Talent; Talent Management; Leadership; Innovation and Invention; Transformation; Organizational Culture; Customer Focus and Relationships; Change Management; Talent and Talent Management; Supply Chain; Mission and Purpose
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (B)." Harvard Business School Supplement 421-037, December 2020. (Revised January 2022.)
- 13 May 2021
- News
Workers Begin Return To A Changed Office Landscape
- April 18, 2022
- Article
Will mRNA Technology Companies Spawn Innovation Ecosystems?
By: Christoph Grimpe, Timo Minssen, W. Nicholson Price, II and Ariel Dora Stern
The mRNA technologies that helped rapidly create effective COVID-19 vaccines could become technology platform businesses, which has tremendous implications for players in the world of drug development. These platforms could attract other companies interested in... View Details
Keywords: Health Care; Digital Health; Technology; Innovation; Health Care and Treatment; Technological Innovation; Digital Transformation; Health Industry; United States
Grimpe, Christoph, Timo Minssen, W. Nicholson Price, II, and Ariel Dora Stern. "Will mRNA Technology Companies Spawn Innovation Ecosystems?" Harvard Business Review (website) (April 18, 2022).
- 13 Oct 2020
- News
July Is the New January: More Companies Delay Return to the Office
- 12 PM – 1 PM EST, 24 Feb 2021
- Virtual Programming
"Moderna" Case Discussion with CEO Stéphane Bancel
Join Professor Karim Lakhani for an interactive discussion of the new Moderna case, joined by Moderna CEO Stéphane Bancel (MBA 2000, AMP 170). This timely case explores how a company builds a digital organization and leverages artificial intelligence and other digital... View Details
- 10 Aug 2021
- News
Is Remote Work Here To Stay?
- 09 Feb 2021
- News